Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 ½-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41% of the cells, and deletion of chromosome 7 and 7q in 37% and 66% of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.
Department of Pathology, University of California San Diego Health Sciences, La Jolla, CA 92037-0987, USA. hywang2@ucsd.edu
Huan-You
HY
Wang
Lily Jun-shen
LJ
Huang
Zhaoli
Z
Liu
Rolando
R
Garcia
Shiyong
S
Li
Carlos A
CA
Galliani
D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002460:Cell Line; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics; D020732:Cytogenetic Analysis; D004900:Erythroblasts / Q000473:pathology*; D005260:Female; D005434:Flow Cytometry; D017353:Gene Deletion; D020570:Genes, myb; D006021:Glycophorins / Q000378:metabolism; D006441:Hemoglobin A / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D007621:Karyotyping; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D010051:Ovarian Neoplasms / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012509:Sarcoma / Q000209:etiology* / Q000235:genetics / Q000473:pathology*
D006021:Glycophorins; D006441:Hemoglobin A; D019009:Proto-Oncogene Proteins c-kit
Blood. 2007 Aug 15;110(4):1251-61
17452517
J Clin Invest. 1991 May;87(5):1483-9
1850755
Leukemia. 2007 Feb;21(2):340-50
17170724
Leukemia. 1994 May;8(5):823-6
7514247
Am J Clin Pathol. 2007 Aug;128(2):314-22
17638668
Leukemia. 2009 Dec;23(12):2275-80
19741728
Am J Clin Pathol. 1996 Oct;106(4):462-8
8853033
Clin Exp Med. 2009 Jun;9(2):149-55
19205620
Eur J Haematol. 2001 Sep;67(3):194-8
11737254
Cancer Genet Cytogenet. 2005 Dec;163(2):113-22
16337853
Oncogene. 1999 May 13;18(19):3017-33
10378697
Mol Cell Biol. 1988 Feb;8(2):884-92
2832742
Int J Hematol. 2010 Mar;91(2):303-9
20111912
Acta Med Okayama. 1992 Dec;46(6):407-15
1485535
Am J Surg Pathol. 1993 Oct;17(10):1011-9
8372941
Haematologica. 2002 Feb;87(2):148-53
11836165
Br J Haematol. 1995 Aug;90(4):868-75
7669665
Am J Clin Pathol. 2009 Sep;132(3):426-37
19687319